Format

Send to

Choose Destination
See comment in PubMed Commons below
Elife. 2014 Mar 11;3:e01308. doi: 10.7554/eLife.01308.

Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters.

Author information

1
David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, United States.

Abstract

The extracellular matrix (ECM) is a major component of tumors and a significant contributor to cancer progression. In this study, we use proteomics to investigate the ECM of human mammary carcinoma xenografts and show that primary tumors of differing metastatic potential differ in ECM composition. Both tumor cells and stromal cells contribute to the tumor matrix and tumors of differing metastatic ability differ in both tumor- and stroma-derived ECM components. We define ECM signatures of poorly and highly metastatic mammary carcinomas and these signatures reveal up-regulation of signaling pathways including TGFβ and VEGF. We further demonstrate that several proteins characteristic of highly metastatic tumors (LTBP3, SNED1, EGLN1, and S100A2) play causal roles in metastasis, albeit at different steps. Finally we show that high expression of LTBP3 and SNED1 correlates with poor outcome for ER(-)/PR(-)breast cancer patients. This study thus identifies novel biomarkers that may serve as prognostic and diagnostic tools. DOI: http://dx.doi.org/10.7554/eLife.01308.001.

KEYWORDS:

breast cancer; extracellular matrix; metastasis; proteomics; tumor microenvironment; tumor stroma

PMID:
24618895
PMCID:
PMC3944437
DOI:
10.7554/eLife.01308
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for eLife Sciences Publications, Ltd Icon for PubMed Central
    Loading ...
    Support Center